Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter D R Higgins

Showing results (51-60 of 246) with videos related to

Pageof 25
Sort By:
Therapeutic Advances in Gastroenterology|March 10, 2023
Vedolizumab more likely to be discontinued than ustekinumab in anti-TNF-experienced patients with fistulizing Crohn's diseaseKira L Newman, Laura A Johnson, Ryan W Stidham, et al.
Advances in Pharmacology (San Diego, Calif.)|November 9, 2024
AXL: A novel therapeutic target in IBDBejan J Saeedi, Hannah E Carr, Peter D R Higgins, et al.
Nature Clinical Practice. Gastroenterology & Hepatology|November 3, 2005
Massive lower gastrointestinal bleeding after rejection of pancreatic transplantsPeter D R Higgins, Ramsey K Umar, Jennifer R Parker, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 20, 2014
Increased risk of venous thromboembolic events with corticosteroid vs biologic therapy for inflammatory bowel diseasePeter D R Higgins, Martha Skup, Parvez M Mulani, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 26, 2017
External Validation of a Thiopurine Monitoring Algorithm on the SONIC Clinical Trial DatasetAkbar K Waljee, Kay Sauder, Yiwei Zhang, et al.
The American Journal of Gastroenterology|May 31, 2024
Insurer-Mandated Medication Utilization Barriers are Associated With Decreased Insurance Satisfaction and Adverse Clinical Outcomes: An Inflammatory Bowel Disease Partners SurveyBrad D Constant, Millie D Long, Frank I Scott, et al.
Infectious Diseases (London, England)|May 22, 2016
Elevated fecal calprotectin associates with adverse outcomes from Clostridium difficile infection in older adultsKrishna Rao, Kavitha Santhosh, Jill A Mogle, et al.
Case Reports in Gastrointestinal Medicine|August 27, 2025
Feasibility of a Hospital at Home for Management of Acute Severe Ulcerative Colitis: A Retrospective Case SeriesAnupama A Goyal, Jeffrey A Berinstein, Bishu Shrinivas, et al.
Plos One|January 24, 2017
Serum Glycoproteome Profiles for Distinguishing Intestinal Fibrosis from Inflammation in Crohn's DiseaseRyan W Stidham, Jing Wu, Jiaqi Shi, et al.
Journal of Crohn'S & Colitis|August 14, 2013
Point-counterpoint: Are we overtreating patients with mild ulcerative colitis?Akbar K Waljee, Ryan W Stidham, Peter D R Higgins, et al.
Pageof 25

Showing results (51-60 of 246) with videos related to

Sort By:
Pageof 25
Therapeutic Advances in Gastroenterology|March 10, 2023
Vedolizumab more likely to be discontinued than ustekinumab in anti-TNF-experienced patients with fistulizing Crohn's diseaseKira L Newman, Laura A Johnson, Ryan W Stidham, et al.
Advances in Pharmacology (San Diego, Calif.)|November 9, 2024
AXL: A novel therapeutic target in IBDBejan J Saeedi, Hannah E Carr, Peter D R Higgins, et al.
Nature Clinical Practice. Gastroenterology & Hepatology|November 3, 2005
Massive lower gastrointestinal bleeding after rejection of pancreatic transplantsPeter D R Higgins, Ramsey K Umar, Jennifer R Parker, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 20, 2014
Increased risk of venous thromboembolic events with corticosteroid vs biologic therapy for inflammatory bowel diseasePeter D R Higgins, Martha Skup, Parvez M Mulani, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 26, 2017
External Validation of a Thiopurine Monitoring Algorithm on the SONIC Clinical Trial DatasetAkbar K Waljee, Kay Sauder, Yiwei Zhang, et al.
The American Journal of Gastroenterology|May 31, 2024
Insurer-Mandated Medication Utilization Barriers are Associated With Decreased Insurance Satisfaction and Adverse Clinical Outcomes: An Inflammatory Bowel Disease Partners SurveyBrad D Constant, Millie D Long, Frank I Scott, et al.
Infectious Diseases (London, England)|May 22, 2016
Elevated fecal calprotectin associates with adverse outcomes from Clostridium difficile infection in older adultsKrishna Rao, Kavitha Santhosh, Jill A Mogle, et al.
Case Reports in Gastrointestinal Medicine|August 27, 2025
Feasibility of a Hospital at Home for Management of Acute Severe Ulcerative Colitis: A Retrospective Case SeriesAnupama A Goyal, Jeffrey A Berinstein, Bishu Shrinivas, et al.
Plos One|January 24, 2017
Serum Glycoproteome Profiles for Distinguishing Intestinal Fibrosis from Inflammation in Crohn's DiseaseRyan W Stidham, Jing Wu, Jiaqi Shi, et al.
Journal of Crohn'S & Colitis|August 14, 2013
Point-counterpoint: Are we overtreating patients with mild ulcerative colitis?Akbar K Waljee, Ryan W Stidham, Peter D R Higgins, et al.
Pageof 25